• In June 2026, Aloe Care Health announced an expanded partnership with Home Helpers Home Care to integrate its new ConnectAI wellness calling solution into the Direct Link powered by Aloe Care suite, which Arlo Technologies is progressively incorporating into its connected care portfolio.
• This move highlights how Arlo is extending its reach into the aging-in-place market by supporting AI-driven wellness check-ins, medication reminders, and proactive risk management for in-home care clients.
• Next, we’ll examine how this deeper integration of AI-powered wellness check-ins could influence Arlo’s subscription-led investment narrative.

The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

Arlo Technologies Investment Narrative Recap

To own Arlo, you generally have to believe in its transition from one-off hardware sales to a recurring, AI-enabled services model. The Aloe Care / Home Helpers expansion reinforces that services-driven story in connected care, but it does not fundamentally change the near term focus on growing high-margin subscriptions or the key risk that hardware price pressure and commoditization could compress product margins.

The Aloe Care ConnectAI rollout sits alongside Arlo Secure 6 and its AI features as part of a broader push to deepen recurring service relationships. Together with partnerships like Samsung SmartThings, these offerings help frame the main catalyst around subscription growth and higher value service tiers, rather than purely unit volumes.

Yet, even as AI-powered care use cases expand, investors should be aware that intense price competition in core devices could still...

Arlo Technologies’ narrative projects $643.1 million revenue and $50.3 million earnings by 2029.

Uncover how Arlo Technologies' forecasts yield a $21.40 fair value, a 63% upside to its current price.

Exploring Other Perspectives

Three Simply Wall St Community members currently see Arlo’s fair value tightly clustered between US$21.40 and US$22.26, highlighting how closely some private investors align on upside potential. You can weigh those views against the central catalyst of expanding AI driven subscription revenue, which could be increasingly important if hardware margins come under pressure.

Explore 3 other fair value estimates on Arlo Technologies - why the stock might be worth as much as 70% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Arlo Technologies research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Arlo Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Arlo Technologies' overall financial health at a glance.

Contemplating Other Strategies?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Find 46 companies with promising cash flow potential yet trading below their fair value.
• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.